AIM: To analyse effects of outpatient laser therapy on the course of different forms of bronchial asthma (BA). MATERIAL AND METHODS: The examination has covered 466 patients with BA divided into three groups: group 1 patients received monotherapy with low-intensive laser radiation (LILR); group 2 - LILR plus conventional drug therapy (CDT); group 3 - CDT only. RESULTS: Group 1 and 2 patients achieved improvement after 2-3 sessions. Asphyxia attacks were less frequent and severe. These attacks disappeared to session 7-10, 10-12 in patients with exogenic, endogenic and mild, moderate mixed BA, respectively. The patients recovered sensitivity to sympathomimetics and methylxantines. Glucocorticosteroids (GCS) doses, hospital stay and temporary disability duration decreased. These two groups achieved remission within 0.5-1 year in 50% patients. Remission for 1-2 years was observed in 40% patients while in group. 3 - in 14%. CONCLUSION: The addition of laser therapy improves a BA course, results of outpatient treatment and rehabilitation, recovers bronchial sensitivity to sympathomimetics and xantine derivatives, reduces GCS dose and duration of hospital stay and disability in BA patients.
AIM: To analyse effects of outpatient laser therapy on the course of different forms of bronchial asthma (BA). MATERIAL AND METHODS: The examination has covered 466 patients with BA divided into three groups: group 1 patients received monotherapy with low-intensive laser radiation (LILR); group 2 - LILR plus conventional drug therapy (CDT); group 3 - CDT only. RESULTS: Group 1 and 2 patients achieved improvement after 2-3 sessions. Asphyxia attacks were less frequent and severe. These attacks disappeared to session 7-10, 10-12 in patients with exogenic, endogenic and mild, moderate mixed BA, respectively. The patients recovered sensitivity to sympathomimetics and methylxantines. Glucocorticosteroids (GCS) doses, hospital stay and temporary disability duration decreased. These two groups achieved remission within 0.5-1 year in 50% patients. Remission for 1-2 years was observed in 40% patients while in group. 3 - in 14%. CONCLUSION: The addition of laser therapy improves a BA course, results of outpatient treatment and rehabilitation, recovers bronchial sensitivity to sympathomimetics and xantine derivatives, reduces GCS dose and duration of hospital stay and disability in BA patients.
Authors: A Brito; T Santos; K Herculano; M Miranda; A K Sá; J L Carvalho; R Albertini; H Castro-Faria-Neto; A P Ligeiro-de-Oliveira; Flávio Aimbire Journal: Inflammation Date: 2021-03-17 Impact factor: 4.092